A CLINICAL EVALUATION OF GOMUTRA HARITAKI ON GARBHASHAYA ARBUDA (UTERINE FIBROID)
Keywords:
Garbhashaya Arbuda, Gomutra Haritaki, Uterine fibroidAbstract
Uterine fibroid (fibromyoma/leomyoma) is the most common benign neoplasm, found approximately 20% to 40% women of reproductive age group. Garbhashaya Arbuda is not directly mentioned in Ayurveda, but on the basis of etiopathology, Doshas, Dushyas, Srotodusti, symptoms and complication for Arbuda can be correlated with uterine fibroid. It is the need of the era that, a secure, less expensive more effective therapy for this sensitive problem should be developed. Patients of reproductive or perimenopausal age with having complaint of menstrual abnormality, dysmenorrhoea, dyspareunia, pressure symptoms, lower abdominal or pelvic pain, abdominal enlargement, infertility etc., investigated with the help of Ultrasonography for confirmation were selected. Total 17 patients were registered, out of them 15 patients completed the course of treatment. Gomutra Haritaki (3gm) was given orally before meal for 3months (with Anupana of Madhu). The drug had shown significant result on symptoms like, Excessive bleeding, dysmenorrhoea, irregular menses, lower abdominal pain, obesity and reducing fibroid size. From the above study it has concluded that the drug Gomutra Haritaki is effective to manage symptoms as well as growth of Garbhashaya Arbuda (Uterine fibroid) with no apparent evidence of complication.
Downloads
Published
How to Cite
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
